| Primary |
| Product Used For Unknown Indication |
23.2% |
| Drug Use For Unknown Indication |
12.5% |
| Gastrooesophageal Reflux Disease |
12.5% |
| Gastritis |
8.9% |
| Overdose |
8.9% |
| Dyspepsia |
5.4% |
| Gastric Ulcer |
5.4% |
| Barrett's Oesophagus |
3.6% |
| Blood Pressure |
3.6% |
| Anxiety |
1.8% |
| Blood Pressure Increased |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Depression |
1.8% |
| Gastric Disorder |
1.8% |
| Gastritis Prophylaxis |
1.8% |
| Hypertension |
1.8% |
| Palliative Care |
1.8% |
| Reflux Oesophagitis |
1.8% |
|
| Product Substitution Issue |
12.0% |
| Fatigue |
8.0% |
| Nephritis Interstitial |
8.0% |
| Pancytopenia |
8.0% |
| Alopecia |
4.0% |
| Angioedema |
4.0% |
| Arrhythmia |
4.0% |
| Drug Ineffective |
4.0% |
| Dysgeusia |
4.0% |
| Dyspnoea |
4.0% |
| Gynaecomastia |
4.0% |
| Hyporeflexia |
4.0% |
| Idiopathic Thrombocytopenic Purpura |
4.0% |
| Multiple Drug Overdose |
4.0% |
| Neutrophil Percentage Decreased |
4.0% |
| Pco2 Increased |
4.0% |
| Pharmaceutical Product Counterfeit |
4.0% |
| Pyrexia |
4.0% |
| Rash Maculo-papular |
4.0% |
| Red Blood Cell Count Decreased |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
36.2% |
| Drug Use For Unknown Indication |
17.6% |
| Overdose |
10.1% |
| Lupus Nephritis |
8.0% |
| Dyspepsia |
4.8% |
| Gastrooesophageal Reflux Disease |
3.7% |
| Gastritis |
2.7% |
| Inflammation |
2.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.1% |
| Hypertension |
1.6% |
| Impaired Gastric Emptying |
1.6% |
| Anorexia |
1.1% |
| Anxiety |
1.1% |
| Appetite Disorder |
1.1% |
| Depression |
1.1% |
| Hepatic Function Abnormal |
1.1% |
| Hypersensitivity |
1.1% |
| Hypothyroidism |
1.1% |
| Increased Appetite |
1.1% |
| Irritable Bowel Syndrome |
1.1% |
|
| Diabetes Mellitus Inadequate Control |
17.4% |
| Pancreatic Carcinoma |
10.9% |
| Wound Infection |
10.9% |
| Hypoventilation |
6.5% |
| Loss Of Consciousness |
6.5% |
| Multiple Drug Overdose Intentional |
6.5% |
| Depressed Level Of Consciousness |
4.3% |
| Interstitial Lung Disease |
4.3% |
| Stomatitis |
4.3% |
| Urticaria |
4.3% |
| Weight Increased |
4.3% |
| Blood Ph Decreased |
2.2% |
| Blood Pressure Decreased |
2.2% |
| Coma Scale Abnormal |
2.2% |
| Dyspnoea |
2.2% |
| Erythema |
2.2% |
| Fatigue |
2.2% |
| Granuloma |
2.2% |
| Hypotension |
2.2% |
| Lymphocyte Stimulation Test Positive |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.1% |
| Rheumatoid Arthritis |
19.1% |
| Product Used For Unknown Indication |
10.7% |
| Hepatitis C |
9.4% |
| Hypertension |
7.6% |
| Prophylaxis |
5.9% |
| Crohn's Disease |
3.5% |
| Gastritis |
3.5% |
| Insomnia |
2.8% |
| Osteoporosis |
2.5% |
| Type 2 Diabetes Mellitus |
2.0% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Hyperlipidaemia |
1.8% |
| Depression |
1.5% |
| Diabetes Mellitus |
1.5% |
| Gastric Cancer |
1.5% |
| Constipation |
1.3% |
| Chronic Myeloid Leukaemia |
1.2% |
| Dyspepsia |
1.2% |
| Multiple Myeloma |
1.2% |
|
| White Blood Cell Count Decreased |
10.6% |
| Pyrexia |
8.0% |
| Vomiting |
7.4% |
| Death |
6.9% |
| Interstitial Lung Disease |
6.4% |
| Respiratory Failure |
6.4% |
| Haemoglobin Decreased |
5.9% |
| Pneumonia |
5.9% |
| Dyspnoea |
5.3% |
| Weight Decreased |
4.8% |
| Anaemia |
3.7% |
| International Normalised Ratio Increased |
3.7% |
| Platelet Count Decreased |
3.7% |
| Cardiac Failure |
3.2% |
| Renal Disorder |
3.2% |
| Ventricular Tachycardia |
3.2% |
| Weight Increased |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Decreased Appetite |
2.7% |
| Dizziness |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
75.0% |
| Epilepsy |
25.0% |
|
| Loss Of Consciousness |
50.0% |
| Somnolence |
50.0% |
|
